Science’s 2024 Breakthrough of the Year: Opening the door to a new era of HIV prevention
A drug with a novel mechanism protects people against the AIDS virus for 6 months. It could speed the end of the epidemic—if those who need it most get access
A drug with a novel mechanism protects people against the AIDS virus for 6 months. It could speed the end of the epidemic—if those who need it most get access
Amid expectations for a rise in M&A activity, market watchers are keeping their eyes on biopharma companies that are ripe for the taking.
Can active inference model consciousness? We offer three conditions implying that it can. The first condition is the simulation of a world or reality model,…
Memories are encoded by sparse populations of neurons but how such sparsity arises remains largely unknown. We found that a neuron’s eligibility to be recruited…
Combined market cap falls 2% year over year, with 16 of the largest public companies losing value and just 5 outperforming the S&P 500.
Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate fordadistrogene movaparvovec after acknowledging the sudden death…
GEN’s updated A-List of top 10 best-selling prescription drugs, based on 2023 sales, has seven of last year’s 10 top-selling drugs registered year-over-year sales gains,…
Research successes are driving gene therapy for inherited deafness to the clinic, but commercialization efforts are needed to sustain momentum.
Carcinotech can generate hundreds of printed tumors from one biopsy, intensifying cancer drug screening and personalized medicine testing.
Deciphering the complex interplay between neuronal activity and mitochondrial function is pivotal in understanding brain aging, a multifaceted process marked by declines in synaptic function…
Clinical trial results suggest that five out of six children treated with a gene therapy for hearing loss demonstrated hearing recovery.